MEDIA

Publications

PEF as a multilayer barrier technology: a sustainable way to enable long shelf life in PET bottles

Aug 3, 2020 | 2020, Publication

Avantium Renewable Polymers, a 100% subsidiary of Avantium, plans to build a flagship plant for the production of FDCA (furandicarboxylic acid), a monomer for high performance polyesters such as PEF (polyethylene furanoate). The plant, which is aimed to be on-stream...

Applying an attitude network approach to consumer behaviour towards plastic

May 14, 2020 | Publication

In a time of rapid climate change, understanding what may encourage sustainable consumer behaviour is a vital but difficult challenge. Using an attitude network approach, we investigated which associations people have towards conventional and bio-based plastic in...

Pilot plant studies of hydrotreating catalysts

Mar 24, 2020 | Publication

Studies of catalysts for hydrotreating lubricant base oil delivered similar results from conventional and high throughput pilot plants Proposed catalyst systems for a lubricant base oil hydrotreater were evaluated with two pilot plant studies. Both studies...

A combination fit for future sustainable barrier packaging solutions- PET and PEF

Mar 9, 2020 | Publication

A combination fit for future sustainable barrier packaging solutions - PET and PEF. Read the article in the PETnology (issue 03 / 2020). Poly(ethylene 2,5-furandicarboxylate) (PEF) has a barrier that is reported to be up to 19x better on CO21 and up to 10x better on...

Confusion about biopolymer and biodegradation

Sep 25, 2019 | Column

Consumers are confused. The general public assumes that bio-based polymers are biodegradable and because biodegradability is considered a positive attribute, this confusion is often cherished rather than clarified. In his column in Chemistry Today (G.J.M. Gruter in...

PEF – the polymer for the future

Sep 5, 2019 | Publication

PEF is a polymer of the future with superior properties and so many possibilities for application. Read the article about PEF in the PETplanet Insider (issue 09 / 2019). Polyethylene 2,5-furandicarboxylate, or PEF for short, is a novel polymer with a chemical...

Avantium produces first plant-based pouches of BOPEF film

Apr 1, 2019 | Publication

Avantium produces the first renewable pouches, made of BOPEF film and bio-PE. Read the article about the pouches in the BioPlastics Magazine (issue 04 2019, page 23).

Michelle Jou

Michelle Jou joined the Supervisory Board of the Company in 2020. She has over 20 years of professional experience in the chemical industry in Asia and Europe, where she has served in a variety of positions in sales, marketing and supply chain management. In 2003, Michelle Jou joined Covestro (formerly Bayer MaterialScience) in the company’s central departments in Shanghai. She later took on the role of VP of the Polycarbonates Business Unit in China and Hong Kong. In 2012 Mrs. Jou was named Senior VP of Commercial Operations in the Asia region. In 2016, she became President of Covestro’s global Polycarbonates Segment, headquartered in Shanghai.

Mrs. Michelle B.B. Jou (1969) holds a Bachelor of Arts degree in French from Fu-Jen University (Taiwan) and an MBA from the EMLYON Business School (France). She is fluent in Mandarin, Cantonese, French and English.

Bart Welten

Chief Financial Officer

Mr Welten will bring 30 years in finance to Avantium and has extensive experience in the chemical and life-sciences industries. He most recently served as the CFO of Centrient Pharmaceuticals (formerly the joint-venture of DSM and Sinochem) in Singapore. Before he left Centrient, he managed the sale of the company to Bain Capital. Prior to this, Mr Welten held the position of CFO of DSM Resins and DSM Anti-Infectives. He holds a law degree from Leiden University (Netherlands) and an MBA from Boston College (USA).

Edwin Moses

Chair

Edwin Moses (chairman) joined the Supervisory Board of the Company in December 2019.

Edwin Moses is a serial entrepreneur and value creator in European life science companies. He has expertise in high value service provision to the pharmaceutical industry and in drug discovery and development. His primary focus is on high growth businesses and change management. Mr. Moses has 25 years of Board level experience in more than 10 companies, mostly as Chairman.

Edwin Moses is Chairman of the Supervisory Board and member of the Audit Committee.